BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23245384)

  • 1. Altered stress induced by partial transection of the infraspinatus tendon leads to perlecan (HSPG2) accumulation in an ovine model of tendinopathy.
    Melrose J; Smith MM; Smith SM; Ravi V; Young AA; Dart AJ; Sonnabend DH; Little CB
    Tissue Cell; 2013 Feb; 45(1):77-82. PubMed ID: 23245384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achilles and tail tendons of perlecan exon 3 null heparan sulphate deficient mice display surprising improvement in tendon tensile properties and altered collagen fibril organisation compared to C57BL/6 wild type mice.
    Shu CC; Smith MM; Appleyard RC; Little CB; Melrose J
    PeerJ; 2018; 6():e5120. PubMed ID: 30042881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of aggrecan and ADAMTS expression in ovine tendinopathy induced by altered strain.
    Smith MM; Sakurai G; Smith SM; Young AA; Melrose J; Stewart CM; Appleyard RC; Peterson JL; Gillies RM; Dart AJ; Sonnabend DH; Little CB
    Arthritis Rheum; 2008 Apr; 58(4):1055-66. PubMed ID: 18383380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
    Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
    Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
    Farach-Carson MC; Warren CR; Harrington DA; Carson DD
    Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration.
    Hayes AJ; Farrugia BL; Biose IJ; Bix GJ; Melrose J
    Front Cell Dev Biol; 2022; 10():856261. PubMed ID: 35433700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal variations in gene expression, histology and biomechanics in an ovine model of tendinopathy.
    Biasutti S; Dart A; Smith M; Blaker C; Clarke E; Jeffcott L; Little C
    PLoS One; 2017; 12(10):e0185282. PubMed ID: 29023489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of proteoglycans in tendon.
    Rees SG; Dent CM; Caterson B
    Scand J Med Sci Sports; 2009 Aug; 19(4):470-8. PubMed ID: 19422635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perlecan and tumor angiogenesis.
    Jiang X; Couchman JR
    J Histochem Cytochem; 2003 Nov; 51(11):1393-410. PubMed ID: 14566013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of achilles tendon reconstruction.
    Zantop T; Gilbert TW; Yoder MC; Badylak SF
    J Orthop Res; 2006 Jun; 24(6):1299-309. PubMed ID: 16649228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
    Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
    Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
    Shu CC; Smith SM; Little CB; Melrose J
    Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tendinopathy--from basic science to treatment.
    Riley G
    Nat Clin Pract Rheumatol; 2008 Feb; 4(2):82-9. PubMed ID: 18235537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tendon healing in vitro: modification of tenocytes with exogenous vascular endothelial growth factor gene increases expression of transforming growth factor beta but minimally affects expression of collagen genes.
    Wang XT; Liu PY; Tang JB
    J Hand Surg Am; 2005 Mar; 30(2):222-9. PubMed ID: 15781343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perlecan, the "jack of all trades" proteoglycan of cartilaginous weight-bearing connective tissues.
    Melrose J; Hayes AJ; Whitelock JM; Little CB
    Bioessays; 2008 May; 30(5):457-69. PubMed ID: 18404701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of FGF-2 binding to chondrocytes from the developing growth plate by perlecan.
    Govindraj P; West L; Smith S; Hassell JR
    Matrix Biol; 2006 May; 25(4):232-9. PubMed ID: 16481152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of proteoglycans in tendinopathy.
    Parkinson J; Samiric T; Ilic MZ; Cook J; Handley CJ
    J Musculoskelet Neuronal Interact; 2011 Jun; 11(2):86-93. PubMed ID: 21625045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can platelet-rich plasma enhance tendon repair? A cell culture study.
    de Mos M; van der Windt AE; Jahr H; van Schie HT; Weinans H; Verhaar JA; van Osch GJ
    Am J Sports Med; 2008 Jun; 36(6):1171-8. PubMed ID: 18326832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
    Winkler S; Stahl RC; Carey DJ; Bansal R
    J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.